Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
Weijun Shen, Brandon L. Taylor, Qihui Jin, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Single-Cell Transcriptomics of the Human Endocrine Pancreas
Yue J. Wang, Jonathan Schug, Kyoung‐Jae Won, et al.
Diabetes (2016) Vol. 65, Iss. 10, pp. 3028-3038
Open Access | Times Cited: 394
Pancreas regeneration
Qiao Zhou, Douglas A. Melton
Nature (2018) Vol. 557, Iss. 7705, pp. 351-358
Open Access | Times Cited: 331
Pancreatic β Cell Regeneration as a Possible Therapy for Diabetes
Cristina Aguayo‐Mazzucato, Susan Bonner‐Weir
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 57-67
Open Access | Times Cited: 202
Inhibition of DYRK1A Stimulates Human β-Cell Proliferation
Ercument Dirice, Deepika Walpita, Amedeo Vetere, et al.
Diabetes (2016) Vol. 65, Iss. 6, pp. 1660-1671
Open Access | Times Cited: 187
Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases
Li Wang, Jiajia Li, Li‐jun Di
Medicinal Research Reviews (2021) Vol. 42, Iss. 2, pp. 946-982
Open Access | Times Cited: 126
Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
Rim Hamzé, Etienne Delangre, Stefania Tolu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15287-15287
Open Access | Times Cited: 91
Conformation states of DYRK1A affected by phosphorylation: Explorations from GaMD simulations and deep learning
Jian Wang, Feng Wang, Wanchun Yang, et al.
Journal of Molecular Liquids (2025) Vol. 424, pp. 127066-127066
Closed Access | Times Cited: 2
DYRK1A and cognition: A lifelong relationship
María L. Arbonés, Aurore Thomazeau, Akiko Nakano-Kobayashi, et al.
Pharmacology & Therapeutics (2018) Vol. 194, pp. 199-221
Open Access | Times Cited: 151
Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas
Yue J. Wang, Maria L. Golson, Jonathan Schug, et al.
Cell Metabolism (2016) Vol. 24, Iss. 4, pp. 616-626
Open Access | Times Cited: 144
Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells
Peng Wang, Esra Karaköse, Hongtao Liu, et al.
Cell Metabolism (2018) Vol. 29, Iss. 3, pp. 638-652.e5
Open Access | Times Cited: 136
Signals in the pancreatic islet microenvironment influence β‐cell proliferation
Kristie Aamodt, Alvin C. Powers
Diabetes Obesity and Metabolism (2017) Vol. 19, Iss. S1, pp. 124-136
Open Access | Times Cited: 132
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates
Violeta Georgieva Tsonkova, Fredrik Wolfhagen Sand, Xenia Asbæk Wolf, et al.
Molecular Metabolism (2017) Vol. 8, pp. 144-157
Open Access | Times Cited: 127
Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease
Sima Kianpour Rad, Aditya Arya, Hamed Karimian, et al.
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 3999-4021
Open Access | Times Cited: 123
Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas
Sophie Tritschler, Fabian J. Theis, Heiko Lickert, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 9, pp. 974-990
Open Access | Times Cited: 109
GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration
Courtney Ackeifi, Peng Wang, Esra Karaköse, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 530
Open Access | Times Cited: 105
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics
Dnyandev B. Jarhad, Karishma K. Mashelkar, Hong‐Rae Kim, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 9791-9810
Closed Access | Times Cited: 103
Calcium Signaling in ß-cell Physiology and Pathology: A Revisit
Christiane Klec, Gabriela Ziomek, Martin Pichler, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6110-6110
Open Access | Times Cited: 90
Endogenous Pancreatic β Cell Regeneration: A Potential Strategy for the Recovery of β Cell Deficiency in Diabetes
Fan Zhong, Yan Jiang
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 87
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F. Lindberg, Laurent Meijer
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6047-6047
Open Access | Times Cited: 81
DYRK1A inhibitors for disease therapy: Current status and perspectives
Tong Liu, Yuxi Wang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114062-114062
Closed Access | Times Cited: 76
Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective
Przemysław Grygier, Katarzyna Pustelny, Jakub Nowak, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4009-4024
Open Access | Times Cited: 32
Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases
Mattias F. Lindberg, Emmanuel Deau, Jonas Arfwedson, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4106-4130
Closed Access | Times Cited: 25
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system
Carolina Rosselot, Yansui Li, Peng Wang, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 755
Closed Access | Times Cited: 9
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas
Huan Wang, Aaron Bender, Peng Wang, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 83
The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?
Ratan V. Bhat, Jan Andersson, Shalini Andersson, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S547-S554
Closed Access | Times Cited: 79
Page 1 - Next Page

Scroll to top